It reprograms tumour-associated monocytes to adopt a lipid-accumulating, immunosuppressive phenotype, enhancing PD-L1 expression on Treg cells through IL-10–JNK–STAT3, thus fostering immune evasion [122]. Here, STAT3 is linked to neoplasm.